GALT vs MPLT: stock comparison and AI forecast
Galectin Therapeutics Inc (GALT) and Maplight Therapeutics, Inc. (MPLT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
GALT Galectin Therapeutics Inc
- Market Cap
- $338M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
MPLT Maplight Therapeutics, Inc.
- Market Cap
- $346M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- GALT and MPLT have similar market capitalizations ($338M and $346M).
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | GALT | MPLT |
|---|---|---|
| Market Cap | $338M | $346M |
| P/B Ratio | – | 0.99x |
| EPS | $-0.50 | $-21.22 |
| Book Value/Share | – | $6.27 |
| FCF/Share | – | $-4.22 |
Profitability & Margins
| Metric | GALT | MPLT |
|---|---|---|
| ROA | -187.8% | – |
| ROIC | 11.4% | -85.1% |
Financial Health
| Metric | GALT | MPLT |
|---|---|---|
| Current Ratio | 0.10x | 16.52x |
| D/E Ratio | – | 0.06x |
| Financial Leverage | – | 1.06x |
| Interest Coverage | -9.2x | – |
| Working Capital | -$137M | $299M |
Cash Flow
| Metric | GALT | MPLT |
|---|---|---|
| Operating Cash Flow | -$16M | -$234M |
| Free Cash Flow | – | -$235M |
| Capital Spending | – | -$520K |
Income Statement
| Metric | GALT | MPLT |
|---|---|---|
| Operating Income | -$16M | -$297M |
| Net Income | -$28M | – |
| R&D Expense | $9M | $245M |
Dividend & Shareholder Information
| Metric | GALT | MPLT |
|---|---|---|
| Shares Outstanding | 101M | 56M |
GALT vs MPLT: stock comparison and AI forecast
Which is bigger, GALT or MPLT?
GALT and MPLT have similar market capitalizations ($338M and $346M).
Which one does Intratio's AI model rank higher, GALT or MPLT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.